desipramine has been researched along with tubocurarine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Blöchl, A; Dominiak, P | 1 |
| Chang, CC; Tang, SS | 1 |
| De Robertis, E; Fiszer, S | 1 |
| Dendorfer, A; Dominiak, P; Raasch, W; Ziegler, A | 1 |
6 other study(ies) available for desipramine and tubocurarine
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Catecholamines; Corticosterone; Desipramine; Epinephrine; Heart; Myocardium; Norepinephrine; Ramipril; Rats; Rats, Inbred SHR; Tubocurarine; Vagotomy | 1991 |
Differentiation between intrinsic and extrinsic acetylcholine receptors of the chick biventer cervicis muscle.
Topics: Acetylcholine; Animals; Bungarotoxins; Chickens; Cholinesterase Inhibitors; Desipramine; Echothiophate Iodide; Electric Stimulation; In Vitro Techniques; Muscle Contraction; Muscles; Neuromuscular Junction; Neurons; Physostigmine; Receptors, Cholinergic; Snakes; Time Factors; Tritium; Tubocurarine; Venoms | 1974 |
Subcellular distribution and chemical nature of the receptor for 5-hydroxytryptamine in the central nervous system.
Topics: Animals; Basal Ganglia; Binding Sites; Brain; Carbon Isotopes; Cats; Cell Membrane; Cell Nucleus; Chromatography, Thin Layer; Desipramine; Ergolines; Gangliosides; Hypothalamus; In Vitro Techniques; Lipoproteins; Mesencephalon; Microsomes; Mitochondria; Myelin Sheath; Nerve Endings; Receptors, Drug; Reserpine; Serotonin; Tubocurarine | 1969 |
Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation.
Topics: Adrenergic alpha-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Atropine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Desipramine; Diastole; Dose-Response Relationship, Drug; Losartan; Male; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Reserpine; Sympathectomy, Chemical; Sympathetic Nervous System; Symporters; Tetrazoles; Tubocurarine; Yohimbine | 2004 |